The case, published in Frontiers in Neuroscience by neurosurgeons at Nara Medical University and collaborators at the Montreal Neurological Institute, describes a 29-year-old woman whose epilepsy had resisted every conventional therapy. Her medical history was extraordinarily complex. At age seven she was diagnosed with a suprasellar germ cell tumor, a rare growth near the pituitary region, and underwent craniotomy for resection, high-dose chemotherapy, whole-brain radiation totaling 50 Gy with a local boost, and stereotactic radiation to the anterior spinal cord at 24 Gy. The tumor went into remission, but the aggressive treatment left her with panhypopituitarism and severe intellectual disability, with a full-scale intelligence quotient of 42 measured at age 16. A ventriculoperitoneal shunt was later inserted to manage secondary hydrocephalus, a buildup of cerebrospinal fluid, but the device caused intracranial hemorrhage from overshunting and had to be ligated.

Seizures emerged at age 22 after an episode of nonconvulsive status epilepticus triggered by severe hyponatremia, a sodium level of 123 mmol/L against a reference range of 135 to 145. Magnetic resonance imaging revealed abnormal lesions in both temporal lobes, and recurrent seizures followed. Over the next seven years she tried levetiracetam, carbamazepine, perampanel, lacosamide, valproic acid, topiramate, and brivaracetam, with either no benefit or intolerable side effects. Vagus nerve stimulation, implanted at age 23, reduced dramatic falls from several per week to one or two, but daily seizures persisted at a rate of roughly ten per day. By the time she reached the Nara epilepsy clinic at 29, her team faced a patient whose brain had been reshaped by tumor, surgery, radiation, and shunt hardware, and whose seizures continued unabated.

The diagnostic workup was exhaustive. Neurological examination showed right-sided hemiparesis with manual muscle strength of grade 3, no meaningful speech, and an inability to follow verbal commands, which ruled out formal neuropsychological testing. Her seizures followed a distinctive pattern: asymmetric tonic posturing lasting 10 to 30 seconds, with eyes deviating to the left, the left arm extending, and the right arm flexing, followed by a flaccid atonic phase in which all four limbs went limp and the trunk tilted leftward. Computed tomography revealed brain atrophy, hydrocephalus, calcifications in both basal ganglia, and post-craniotomy changes in the right frontal region. Magnetic resonance imaging showed marked atrophy of the left hemisphere, so severe that the left anterior thalamic nucleus could not be identified at all.

Video-electroencephalography over three days, using scalp electrodes placed according to the International 10-20 system, painted a detailed electrical portrait. Between seizures, the awake recording showed a disorganized posterior dominant rhythm of 6 to 7 hertz, frequent slow and sharp waves over the F4 and C4 electrode positions on the right, and spikes with high-amplitude fast activity at sleep onset. Sleep architecture was disrupted, without obvious slow-wave sleep, and intermixed abnormal theta and delta activity was maximal over the left frontal region, with independent interictal epileptiform discharges also appearing in the right frontotemporal region. Crucially, the team captured around ten habitual seizures, and ictal recordings showed high-amplitude bursts of spiky fast waves originating at F4 and spreading across the right hemisphere. Frequent subclinical electrographic seizures occurred during sleep. The diagnosis: focal epilepsy arising from a widespread epileptogenic network centered on the right frontal and temporal lobes.

That network localization shaped the surgical decision. Because the epileptogenic zone was distributed rather than confined to a resectable focus, focal removal was not indicated; resective surgery can render roughly two-thirds of medial temporal lobe epilepsy patients seizure-free and about half of those with neocortical epilepsy, but only when the abnormal tissue can be cleanly delineated. Deep brain stimulation of the anterior thalamic nucleus was chosen instead. The original plan was conventional bilateral implantation, but anatomy intervened. The left nucleus could not be visualized on imaging, even when compared against ultrahigh-resolution 200-micrometer sections from the BigBrain human atlas. Severe left hemispheric atrophy had widened the subdural space excessively, and a shunt valve sat at the anticipated burr-hole site beneath thinned scalp. With the epileptiform abnormalities predominantly right-sided, and with prior animal studies and human responsive neurostimulation cases suggesting unilateral thalamic stimulation could work, the team implanted a single electrode in the right anterior nucleus alone.

Stimulation began seven days after surgery at an intensity of 2 milliamperes, and the results were striking. Seizure frequency plummeted from roughly ten per day to about one, an early drop the authors attribute largely to a microlesioning effect, the temporary suppression that often follows electrode implantation itself rather than the stimulation. Once that effect settled, sustained stimulation produced a stable seizure reduction of approximately 60 percent, maintained throughout nine months of follow-up. Antiseizure medications were left unchanged, isolating the stimulation as the variable. Seizure duration also shortened by about half, reducing interruptions to daily life, and the patient showed improved daytime alertness, possibly reflecting better nighttime sleep quality, which in turn eased the burden on her caregivers. Final stimulation parameters were set at 2 mA, 145 pulses per second, 90-microsecond pulse width, and a duty cycle of one minute on and five minutes off, while vagus nerve stimulation was reduced to 1 mA. Routine postoperative electroencephalography showed a measurable reduction in interictal epileptiform discharges, and no surgery- or stimulation-related adverse events occurred.

The result fits a broader pattern in neuromodulation. In movement disorders such as Parkinson’s disease, unilateral deep brain stimulation of the subthalamic nucleus or internal globus pallidus improves contralateral symptoms by up to 75 percent but ipsilateral symptoms by only about 28 percent, and a recent systematic review found unilateral stimulation improved Unified Parkinson’s Disease Rating Scale Part III scores by 37 percent compared with up to 66 percent for bilateral approaches. The principle is that one electrode primarily treats the hemisphere in which it sits. Epilepsy complicates this logic, because seizures can propagate through the thalamus to widespread networks on both sides, which is precisely why bilateral anterior thalamic stimulation became standard. Yet animal work supports the one-sided approach in the right circumstances: in rats with unilateral amygdala kindling, high-frequency stimulation of the ipsilateral anterior nucleus significantly reduced seizure frequency and duration, while contralateral stimulation did not, although in a pilocarpine model of secondarily generalized seizures only bilateral stimulation or lesioning suppressed seizures.

Human case reports of responsive neurostimulation, a closed-loop device that fires only when it detects seizure activity, point the same way. One patient with refractory genetic generalized epilepsy achieved a 90 to 95 percent seizure reduction over two years with stimulation of the right anterior nucleus and prefrontal cortex, and three patients with multifocal epilepsy treated with unilateral thalamic responsive neurostimulation improved by 50 to 56 percent over 33 to 35 months. Although closed-loop and open-loop stimulation differ mechanistically, both experiences underscore the importance of targeting the hub of the epileptogenic network. The Nara case strengthens that hypothesis because open-loop stimulation alone, delivered continuously between seizures, achieved meaningful control, and its effects may continue to evolve over longer periods. The authors also note that the anterior nucleus and medial temporal structures are both components of the limbic system, and that stronger functional connectivity between the thalamus and the seizure onset zone has been linked to better stimulation outcomes, which may explain why unilateral stimulation worked when the network was predominantly ipsilateral.

The team is careful about the limits of a single case. The follow-up was only nine months, so durability remains unknown, and the pre-existing vagus nerve stimulator complicates attribution, since a synergistic effect between the two devices cannot be excluded. Still, the clinical message is concrete: when the predominant epileptogenic network is confined to one hemisphere, and especially when anatomical constraints such as atrophy, shunt hardware, or distorted anatomy prevent placing electrodes on both sides, unilateral anterior thalamic stimulation is a reasonable and potentially worthwhile option. The authors caution that bilateral stimulation remains necessary when seizures arise from or spread through both hemispheres, as in post-encephalitic epilepsy, and that larger cohorts with longer follow-up are needed to define the indications, efficacy, and durability of the unilateral approach. For now, the case offers a carefully documented proof of principle that in epilepsy surgery, as in so much of neuroscience, matching the intervention to the individual patient’s network may matter more than following the standard template.

Subject of Research: Unilateral deep brain stimulation of the anterior thalamic nucleus for drug-resistant focal epilepsy

Article Title: Case Report: Successful treatment of drug-resistant epilepsy with unilateral deep brain stimulation of the anterior nucleus of the thalamus

Article References: Sasaki, R., Yamada, K., Tamura, K., Kinoshita, M., Park, Y.-S., Sadikot, A. F., & Nakagawa, I. (2026). Case Report: Successful treatment of drug-resistant epilepsy with unilateral deep brain stimulation of the anterior nucleus of the thalamus. Frontiers in Neuroscience, 20, Article 1978183. https://doi.org/10.3389/fnins.2026.1978183

Image Credits: AI Generated

DOI: 10.3389/fnins.2026.1978183

Keywords: deep brain stimulation, drug-resistant epilepsy, anterior nucleus of the thalamus, neuromodulation, focal epilepsy, case report, electroencephalography, vagus nerve stimulation, thalamus, epilepsy surgery, responsive neurostimulation, neuroscience

The research, conducted by Tristan Baumann and Oxana Eschenko at the Max Planck Institute for Biological Cybernetics in Tübingen, Germany, tackled a long-standing puzzle in systems neuroscience. The hippocampus and prefrontal cortex cooperate closely during spatial navigation, spatial working memory, and memory consolidation, yet their direct anatomical wiring is strikingly asymmetric. The prefrontal cortex sends substantial projections into the hippocampal formation, but the hippocampus receives only limited direct input from the prefrontal cortex. This imbalance has led scientists to ask how bidirectional communication between the two regions is achieved, and which intermediary structures carry the traffic.

The nucleus reuniens, a midline nucleus of the thalamus, is anatomically well positioned to fill this role. It receives input from the deep layers of the prelimbic and infralimbic cortices, projects back to both superficial and deep cortical layers, and is densely innervated by the ventral hippocampus and subiculum, from which it projects to the distal dendritic layer of ventral CA1. Some reuniens neurons even send branching axons, or collaterals, to both the hippocampus and the prefrontal cortex, providing a plausible substrate for simultaneously modulating both regions. Decades of lesion and inactivation studies have shown that disrupting the reuniens impairs spatial working memory, memory consolidation, and memory retrieval, while leaving tasks that depend on the hippocampus or prefrontal cortex alone largely intact, suggesting it is specifically required when the two regions must coordinate.

What remained unclear was whether the reuniens acts as a passive relay, simply forwarding signals between hippocampus and cortex, or as an active integrator that transforms information. The two hypotheses make different predictions. If the nucleus were a simple relay, learning-related changes should propagate symmetrically across both the hippocampus-to-reuniens and reuniens-to-prefrontal pathways. An active integrator, by contrast, would show asymmetric directional coupling, pathway-selective modulation, and dynamics that depend on behavioral state. To distinguish these possibilities, the researchers recorded local field potentials simultaneously from the deep layers of the prelimbic cortex, from CA1 of the dorsal hippocampus, and from the nucleus reuniens itself while six adult male rats learned to navigate a complex elevated maze across seven days.

The maze was deliberately demanding. Built as a crossword-like lattice with multiple intersections and dead ends, it offered two starting points equidistant from a single reward port, with salient visual cues providing an allocentric reference frame. The optimal path required six navigational decisions from one start and four from the other, and training was capped at seven sessions of ten trials each to minimize reliance on procedural memory. All rats located the reward within the first one or two sessions, and performance improved steadily across days, with trial duration, running velocity, and navigation errors all showing strong learning effects. The researchers then analyzed 364 artifact-free trials using spectral power, coherence, and Granger causality measures, embedding each in linear mixed-effects models that controlled for running speed, since locomotion is known to modulate neural oscillations.

The first surprise came from the theta band, the 6 to 11 Hz rhythm long considered the workhorse of hippocampal-prefrontal communication. As expected, velocity strongly predicted theta power in the hippocampus and, more weakly, in the reuniens, but not in the prefrontal cortex. Yet after statistically removing the contribution of speed, theta power decreased across learning in all three regions, even though the animals ran faster as they improved. In other words, the rats’ brains became less theta-dominant precisely as their navigation became more skilled, a dissociation the authors interpret as evidence that local network dynamics reorganize with learning independently of changes in movement.

The beta band, roughly 15 to 30 Hz, told an even more intriguing story. Both the hippocampus and reuniens displayed a narrow peak around 16 to 16.5 Hz, which the authors acknowledge could partly be a harmonic, an integer multiple, of the dominant theta rhythm produced by Fourier decomposition of non-sinusoidal signals. But the two regions’ beta signals behaved differently: reuniens beta declined across learning in parallel with theta, whereas hippocampal beta showed a transient increase early in training that dissociated it from theta dynamics. Cross-regional coherence added a further twist. Beta synchrony between hippocampus and reuniens, and between hippocampus and prefrontal cortex, increased with learning, while beta synchrony between reuniens and prefrontal cortex decreased. Control analyses using the volume-conduction-resistant weighted phase-lag index confirmed that these couplings reflected genuine interactions rather than electrical field spread across tissue.

The decisive evidence came from Granger causality, a technique that estimates the direction of information flow between simultaneously recorded signals. Learning selectively strengthened the flow of information from hippocampus to reuniens in the theta, beta, and low-gamma bands, while influences in the opposite direction, from reuniens back to hippocampus, decreased. Direct hippocampal-prefrontal interactions, by contrast, remained comparatively stable throughout learning, with hippocampus-to-prefrontal theta flow driven mainly by running speed rather than by task mastery. Because Granger causality estimates can be inflated by differences in oscillatory power between regions, the authors also computed time-reversed Granger causality, a control that preserves relative power but reverses directionality. The learning-related increase in hippocampus-to-reuniens flow survived this test, confirming that spatial learning genuinely boosted hippocampal influence on the thalamic nucleus rather than merely reflecting the hippocampus’s stronger theta signal.

Taken together, the findings paint a picture of dynamic network reconfiguration driven primarily by the hippocampal, not prefrontal, side of the circuit. The authors propose that theta synchrony may provide a stable communication scaffold linking the three regions, while beta and gamma interactions carry task-specific demands and learning processes. The early rise in hippocampus-to-reuniens beta coupling coincides with the phase of training when behavior is changing most rapidly, consistent with recent proposals that reuniens beta synchrony acts as a neurobiological memory buffer holding task-relevant information during navigation. Meanwhile, the decline in prefrontal-reuniens beta coherence, alongside a transient increase in prefrontal-to-reuniens low-gamma flow, may reflect a shift from novelty-driven prefrontal engagement toward more hippocampus-dominated interactions as spatial representations consolidate.

The authors caution that several questions remain open. Disentangling velocity from learning is inherently difficult when running speed rises with performance, and field-potential connectivity cannot by itself distinguish genuine cross-regional interactions from shared inputs from a third region, nor reveal what information the reuniens neurons actually encode. Pathway-specific causal manipulations will be needed to pin down the cellular mechanisms. Nevertheless, the directional asymmetry the study uncovered, with hippocampal influence on the reuniens strengthening while reuniens output to cortex weakened or held steady, is difficult to reconcile with any simple relay account. Instead, the nucleus reuniens emerges as an active node that receives, transforms, and likely redistributes hippocampal input across its extensive connectivity, a conclusion that reshapes how neuroscientists think about the thalamic contribution to spatial cognition and memory.

Subject of Research: How spatial learning reconfigures information flow within the hippocampus–nucleus reuniens–prefrontal cortex circuit in rats

Article Title: Spatial learning strengthens hippocampal but not prefrontal influence on nucleus reuniens in rats

Article References: Baumann, T., & Eschenko, O. (2026). Spatial learning strengthens hippocampal but not prefrontal influence on nucleus reuniens in rats. Frontiers in Behavioral Neuroscience, 20, Article 1939794. https://doi.org/10.3389/fnbeh.2026.1939794

Image Credits: AI Generated

DOI: 10.3389/fnbeh.2026.1939794

Keywords: nucleus reuniens, hippocampus, prefrontal cortex, spatial learning, theta oscillations, beta oscillations, Granger causality, local field potentials, thalamus, spatial navigation, neural oscillations, memory

The model, developed by Chun-Hui Huang, Wen-Shuo Chen, and colleagues at National Taiwan University and National Taiwan Ocean University, is built on the classic Hodgkin-Huxley formalism, the biophysical framework that describes how voltage-gated ion channels generate action potentials. Rather than lumping brain regions into abstract nodes, the testbed resolves eleven distinct neuronal populations spanning cortex, thalamus, striatum, and the basal ganglia: cortical pyramidal cells, two classes of cortical interneurons, thalamocortical relay cells, reticular thalamic neurons, striatal fast-spiking interneurons, direct- and indirect-pathway medium spiny neurons, neurons of the external and internal globus pallidus, and subthalamic nucleus cells. Each population carries its own complement of sodium, potassium, calcium, and adaptation currents, allowing the simulation to reproduce complex discharge patterns such as the post-inhibitory rebound bursting that emerges from T-type calcium channels in the subthalamic nucleus and thalamus.

To emulate Parkinson’s disease, the researchers did not simply dial down a single parameter. Instead, they reconfigured the network to mimic the circuit-level consequences of dopamine depletion: cortical drive to the direct pathway was weakened, input to the indirect pathway was strengthened, and feedforward inhibition within the striatum was reduced. Background currents to the globus pallidus and subthalamic nucleus were also adjusted, with the subthalamic baseline dropping from 33 to 23 microamps. The calibrated parkinsonian state showed hallmark reorganization: beta-band power, oscillations in the 13 to 30 hertz range associated with rigidity and slowness of movement, rose nearly fourfold in the internal globus pallidus and fourfold in indirect-pathway striatal neurons, while firing rates of the two medium spiny neuron populations shifted dramatically upward.

Against this pathological backdrop, the team ran two interventions on identical networks. The first was conventional: 130-hertz deep brain stimulation of the subthalamic nucleus, delivered as symmetric, charge-balanced biphasic pulses with a pulse width of 0.06 milliseconds per phase. The second was an idealized periodic visual input, generated by a prescribed input unit that delivers rhythmic pulse trains directly to cortical pyramidal cells and thalamic relay cells. The authors are careful to note that this input unit is not a biophysical model of the retina or the lateral geniculate nucleus; it bypasses the sensory filtering that real visual signals undergo, and the archived identifier suggesting a 40-hertz condition is a legacy label—the implemented drive is a 10-hertz base-pulse train, with the 38 to 42 hertz band analyzed purely as an output measure.

The contrast between the two interventions was stark. Deep brain stimulation crushed the model’s internal measure of subthalamic beta-band synaptic current, reducing it from 0.0184 to 0.0018 arbitrary units—a suppression of roughly ninety percent, with a Cohen’s d effect size of 3.9 and a Holm-corrected p-value of 1.1 times ten to the minus fifth power. The periodic visual input did the opposite on this measure: subthalamic beta power actually rose by more than double. But the visual input produced something deep brain stimulation did not. Thalamic relay cell firing jumped from 8.6 to 35.3 hertz, previously silent reticular thalamic neurons woke up to 6.56 hertz, and cortical pyramidal firing nearly doubled from 4.86 to 10.33 hertz, accompanied by significant increases in broadband gamma power and narrowband power in the 38 to 42 hertz window. Deep brain stimulation, by contrast, left cortical firing statistically unchanged.

One of the most intriguing findings concerns what happened to the thalamus under deep brain stimulation. Spontaneous firing of thalamocortical relay cells fell to zero at every tested stimulation amplitude from 1 to 5 milliamps per square centimeter—a result that could, at first glance, suggest the stimulation had silenced the thalamus entirely, acting like a reversible lesion. The team dug deeper. In a full-resolution diagnostic run, they inspected 2.5 million membrane voltage samples from all ten modeled relay cells and found every sample finite and subthreshold, ranging from about -71 to -58 millivolts, with no crossings through zero millivolts. That pattern is inconsistent with sustained depolarization block, the pathological state in which neurons are stuck in a hyperpolarized inactivity. Instead, the data pointed to subthreshold quiescence: the relay cells remained alive and responsive, simply not firing spontaneously under the calibrated balance of excitatory and inhibitory inputs.

To test whether this quiescence depended on one particular parameter, the researchers ran a matched-seed sensitivity analysis on the inhibitory coupling from the internal globus pallidus to the thalamus, varying it by twenty percent in either direction. Across all thirty runs, thalamic spontaneous firing remained at zero, and all 750,000 saved voltage samples stayed subthreshold, between -72 and -55 millivolts. A further three-parameter sensitivity analysis—varying a GABA decay constant, the subthalamic-pallidal coupling conductance, and the subthalamic injected current, each by twenty percent—left all four principal outcomes intact, with beta suppression under deep brain stimulation remaining between 88.9 and 95.8 percent. These checks do not prove the model is robust to every conceivable perturbation, but they show the headline results are not artifacts of a single finely tuned value.

The dose-response story added another layer of nuance. Rather than a clean monotonic relationship between stimulation intensity and beta suppression, the amplitude series revealed a non-monotonic response: at 1 milliamp per square centimeter, subthalamic beta actually increased above the unstimulated parkinsonian baseline, while at 2 through 5 milliamps the mean beta values settled into a narrow band corresponding to over ninety percent suppression. Because no amplitudes between zero and one milliamp were sampled, the exact transition point where thalamic firing collapses remains unresolved. The authors also stress that the model’s current density is not directly translatable to clinical device current, which depends on electrode geometry, volume conduction, and axonal recruitment in real tissue.

The study is equally candid about its boundaries. The subthalamic beta measure is derived from outgoing synaptic current rather than a simulated local field potential, and the model omits the hyper-direct cortico-subthalamic pathway now considered a key driver of beta oscillations in human Parkinson’s disease—perhaps explaining why the canonical parkinsonian rise in subthalamic beta appeared in the pallidum and striatum instead. The simplified non-REM sleep representation failed to reproduce the pathological beta that clinical recordings show can persist during sleep, and the cortical module, with its simplified horizontal inhibition, produced stronger high-beta synchrony than would be expected clinically. The authors frame these as defined targets for future iterations rather than fatal flaws.

What emerges is not a treatment recommendation but a set of sharply defined, testable hypotheses. Deep brain stimulation and rhythmic visual input, in this calibrated network, produce fundamentally different response profiles: one suppresses pathological subthalamic beta while leaving cortical output largely untouched, the other recruits thalamic and cortical activity vigorously without touching the beta measure. Whether visual recruitment preserves information processing, whether thalamic quiescence under stimulation is compatible with faithful relay, and whether either profile translates to motor benefit in patients are questions the model cannot answer. But by placing both interventions on the same digital substrate—complete with wakefulness, sleep, and anesthesia states—the testbed gives experimentalists a concrete map of where to look next, and a reminder that in the brain, suppressing one circuit’s noise and amplifying another’s signal are not the same thing.

Subject of Research: Computational modeling of deep brain stimulation versus periodic visual input in the Parkinsonian cortico-basal ganglia-thalamic circuit

Article Title: An in silico cortico-basal ganglia-thalamic testbed for comparing visual and deep brain stimulation in Parkinson’s disease

Article References: Huang, C.-H., Chen, W.-S., Lai, J.-R., Cho, C.-H., Sung, Y.-T., Chang, C.-T., & Lin, C.-W. (2026). An in silico cortico-basal ganglia-thalamic testbed for comparing visual and deep brain stimulation in Parkinson’s disease. Frontiers in Computational Neuroscience, 20, Article 1950516. https://doi.org/10.3389/fncom.2026.1950516

Image Credits: AI Generated

DOI: 10.3389/fncom.2026.1950516

Keywords: Parkinson's disease, deep brain stimulation, computational neuroscience, Hodgkin-Huxley model, basal ganglia, thalamus, beta oscillations, visual stimulation, neuromodulation, cortico-basal ganglia-thalamic loop, in silico modeling, gamma oscillations

The study took advantage of an unusual clinical circumstance. A 14-year-old boy with generalized secondary dystonia was undergoing staged implantation of deep brain stimulation (DBS) leads as part of his treatment at Children’s Hospital of Orange County. Before the therapeutic electrodes were finalized, temporary stereoelectroencephalography (sEEG) leads were placed in candidate DBS targets, giving the research team a window into brain regions that almost never lend themselves to direct recording in humans. With informed consent from his guardians and approval from the institutional review boards, the team turned a surgical procedure into a scientific experiment on motor timing.

Ten depth leads were implanted bilaterally, reaching the globus pallidus internus (GPi) and subthalamic nucleus (STN) within the basal ganglia, the ventral oralis (Vo) and centromedian (CM) nuclei of the thalamus, and two thalamic nuclei that receive direct projections from the cerebellum: the ventral intermediate nucleus (VIM) and the centrolateral nucleus (CL). Each lead carried low-impedance macro-contacts and high-impedance microwire electrodes, with micro-contact signals sampled at roughly 24 kilohertz and preamplified at the connector to suppress noise and motion artifacts. From these channels, the researchers extracted local field potentials (LFPs), the summed electrical chatter of local neural populations, filtered between 0.05 and 30 hertz.

While the electrodes were in place, the participant performed a classic two-phase timing task drawn from decades of cognitive neuroscience research. In each 18-second trial, an auditory metronome delivered tones every 600 milliseconds for the first 6 seconds, and the boy moved a joystick in sync with the beeps. Then the metronome fell silent. For the remaining 12 seconds, he had to keep the rhythm going from memory alone. This split between synchronization and continuation is the standard way researchers separate externally cued timing, which depends on sensory prediction, from internally generated timing, which relies on the brain’s own clock.

The behavioral data already told an interesting story. During the first three intervals after the metronome started, his movements lagged behind the tones, but he quickly flipped into anticipation, with responses beginning to lead the auditory cues by a stable margin. More striking, he did not simply obey the metronome. His average interval was 557 milliseconds in the cued phase and sped up to 536 milliseconds when the tones stopped, both faster than the prescribed 600 milliseconds. The fact that he carried his own tempo from the cued phase into the continuation phase suggests he was relying on an endogenous timing signal rather than passively entraining to the external beat. His timing variability was actually lower without the metronome, and his Weber fraction, a normalized measure of temporal precision, was 9.45 percent in the continuation phase, somewhat above the roughly 5 percent typical of young adults, a difference the authors attribute to his age, his neurological condition, and the response device.

The neural recordings were the heart of the study. When the researchers averaged LFPs time-locked to joystick movement onset across trials, they found strong, rhythmic modulations in every recorded region, including the cerebellar-recipient VIM and CL. These were not diffuse fluctuations; the signals were phase-locked to the movements, indicating functional coupling between neural activity and motor output at the level of individual actions. Crucially, the amplitude of these time-locked responses was significantly stronger during the synchronization phase than during the continuation phase in all regions, after statistical correction for multiple comparisons. The researchers suggest several interpretations: the larger cued-phase responses may reflect neural reactions to the tones, heightened responsiveness when movement is paired with an auditory stimulus, or activity that monitors the phase relationship between what is heard and what is done.

Time-frequency analysis sharpened the picture further. Scalograms of the joystick signal showed sustained power at approximately 1.8 hertz, matching the participant’s own movement rate, throughout both task phases. The LFPs from the VIM and CL displayed oscillatory power at the same frequency, present while the metronome sounded and remaining stable after it stopped. Across all recorded regions, the power spectra during the task showed a prominent peak near the metronome frequency of 1.667 hertz, standing out clearly against resting baselines recorded before the task began. In other words, the deep motor circuits were oscillating at precisely the frequency of the behavior, in both the externally cued and the internally driven halves of the task. This frequency-specific entrainment across basal ganglia and cerebellothalamic circuits supports the idea that rhythmic timing emerges from coordinated activity distributed across these loops rather than from a single timing center.

The authors are careful about what the oscillations do and do not prove. They note that the rhythmicity of the neural responses likely reflects the iterative operation of an internal interval-timing mechanism rather than an autonomous oscillator ticking away on its own. They also acknowledge a classic confound: in this task, internal timing, motor execution, and sensory feedback are temporally aligned, so the recorded modulations could serve any or all of those functions. Interestingly, the Vo and VIM nuclei showed movement-related oscillations at slightly lower frequencies than other regions, hinting that their distinct inputs from cerebellum and basal ganglia may support an integration process for predictive control over extended intervals. Disentangling these roles, the researchers write, will require task designs that separate the components and, ideally, direct recordings from the cerebellum itself to trace where timing signals originate and how they propagate.

The clinical stakes are considerable. Dystonia is clinically defined by abnormal co-contraction and twisting postures rather than by rhythmic movement, but the study’s authors argue that impaired temporal coordination within subcortical circuits may contribute to that disorganization. If cerebellothalamic and basal ganglia pathways each carry precisely timed, behaviorally locked signals, then the choice of DBS target becomes more than a matter of anatomy; it becomes a question of which timing circuit to modulate. The VIM, which receives excitatory input from the cerebellar dentate nucleus and has been implicated in event timing, and the CL, another cerebellar recipient, emerge as candidate relay sites for timing-related signals within a distributed motor network. Understanding these dynamics could help clinicians tune stimulation parameters to restore temporal stability, not just suppress symptoms.

The researchers also lay out the limits of the work with unusual candor. The dataset comes from a single participant, which constrains generalizability, although several features of the design mitigate concerns that dystonia itself drove the results. The task required only small, controlled joystick movements that were largely unaffected by dystonic posturing, and the analyses focused on low-frequency dynamics around 1 to 2 hertz, bands unlikely to be dominated by dystonia-related activity. The team proposes extending the approach to multi-subject datasets, testing trial-by-trial correlations between LFP power and behavioral precision, and applying cross-regional coherence analysis and computational modeling to separate the contributions of sensory-guided and internally generated timing. For now, the study stands as a vivid demonstration that when the brain keeps a beat, the echo of that beat can be read directly from the circuits that deep brain stimulation is built to reach, and that time itself may be a measurable currency flowing between the basal ganglia and the cerebellar thalamus.

Subject of Research: Neural mechanisms of motor timing in basal ganglia and cerebellothalamic circuits in dystonia

Article Title: Behaviorally coupled oscillations reveal distinct timing roles of basal ganglia and cerebellothalamic circuits in dystonia

Article References: Seyyed Mousavi, S. A., Javadzadeh, S., Asadi, M., Ivry, R. B., & Sanger, T. D. (2025). Behaviorally coupled oscillations reveal distinct timing roles of basal ganglia and cerebellothalamic circuits in dystonia. Dystonia, 4, Article 15390. https://doi.org/10.3389/dyst.2025.15390

Image Credits: AI Generated

DOI: 10.3389/dyst.2025.15390

Keywords: dystonia, deep brain stimulation, motor timing, basal ganglia, cerebellum, thalamus, local field potentials, stereoelectroencephalography, neural oscillations, rhythmic movement, ventral intermediate nucleus, pediatric neurosurgery

The study’s central discovery concerns a trio of structures that most people rarely associate with mood. The cerebellar vermis, a midline strip of the cerebellum traditionally known for coordinating movement, the nucleus accumbens, a key hub of the brain’s reward system, the globus pallidus, a relay station of the basal ganglia, and the ventrolateral nucleus of the thalamus together form what researchers describe as a cerebello-basal ganglia-thalamic circuit. Using Granger causality analysis, a mathematical technique that estimates the direction of information flow between brain regions from the timing of their activity fluctuations, the team found that patients with melancholic depression showed diminished causal outflow from the cerebellar vermis to both the globus pallidus and the thalamic ventrolateral nucleus. They also detected weakened bidirectional connectivity between the thalamic ventrolateral nucleus and the nucleus accumbens, meaning the dialogue between the brain’s sensory relay station and its reward center had gone quiet in both directions.

What makes this pattern scientifically compelling is its specificity. Rather than being a generalized slowdown of brain communication, the hypo-connectivity was concentrated in a defined circuit, and the researchers used directed Network-Based Statistics, a method that tests whether a set of connected brain regions behaves differently between groups, to confirm that the melancholic group differed from healthy controls in this targeted way. The team then correlated these circuit features with clinical characteristics, asking whether the degree of disconnection tracked with the severity of symptoms such as anhedonia, the clinical term for the loss of interest and pleasure that defines melancholic depression. This step matters because a biomarker is only useful if it corresponds to something patients actually experience, and anhedonia is precisely the symptom that most distinguishes melancholic from atypical depression, which instead features mood reactivity and increased appetite or sleep.

To test whether the pattern could serve as a practical diagnostic tool, the researchers turned to machine learning. The connectivity features identified in the exploration dataset, which included 1,175 participants, were used to construct a classification model that was then applied to a completely separate validation dataset of 216 individuals. The model achieved an area under the curve, or AUC, of 0.81, a performance level that indicates the circuit signature can distinguish melancholic depression from other presentations with meaningful accuracy. In clinical research, an AUC of 0.81 falls into the range considered useful for a diagnostic aid, sitting well above the 0.5 that would represent random guessing and approaching the thresholds at which biomarkers begin to inform real-world decisions. For a field in which depression subtypes are still diagnosed largely through subjective clinical interviews, a measurable brain-based feature is a significant step forward.

Perhaps the most important test, however, was whether the pattern persists over time. Many candidate biomarkers in psychiatry fail this test, fluctuating with mood, medication status, or scan conditions in ways that make them unreliable. The third dataset in the study was a longitudinal clinical cohort of 150 participants, each of whom underwent at least two MRI scans. Using repeated-measures analysis of variance, the team confirmed that the hypo-connectivity pattern in the cerebello-basal ganglia-thalamic circuit remained stable within individuals across repeated measurements. This stability is what elevates the finding from an interesting correlation to a potential trait marker, something that could identify the melancholic subtype regardless of whether a patient happens to be scanned during a particularly good or bad week.

The clinical implications reach beyond diagnosis. Melancholic depression is associated with poorer response to standard antidepressant treatment and greater impairment in social and occupational functioning compared with other depression subtypes. If the cerebello-basal ganglia-thalamic circuit represents a genuine circuit-level mechanism, it opens the door to targeted interventions aimed specifically at restoring communication along these pathways. Brain stimulation techniques such as transcranial magnetic stimulation and, in research settings, more precise neuromodulation approaches could in principle be tuned to influence cerebellar or thalamic nodes of this network. The authors suggest that this stable and directional brain network feature may help identify the subtype and guide the development of such targeted treatments, a framing that aligns with a broader movement in psychiatry toward circuit-based rather than symptom-based classification.

The study also adds to a growing body of evidence that the cerebellum, long dismissed as a purely motor structure, plays a substantive role in emotion and motivation. Anatomical tracing work in animals and functional imaging in humans have both shown that the cerebellar vermis maintains reciprocal connections with limbic and reward-related regions, and cerebellar abnormalities have been reported across a range of psychiatric conditions. What this new study contributes is directionality: rather than simply showing that the cerebellum and reward regions are co-active, Granger causality analysis indicates that the flow of influence from the vermis outward to the basal ganglia and thalamus is specifically blunted in melancholic depression. That directional detail matters because it hints at where in the circuit the disruption originates, and because bidirectional weakening between the thalamus and nucleus accumbens suggests the problem is not confined to a single link.

The scale and design of the research strengthen its credibility. With 1,541 participants divided into exploration, validation, and longitudinal components, the study follows a structure that mirrors the standards of clinical test development: discover a signal in one cohort, verify it in an independent cohort, and then confirm its temporal stability in a third. The work was supported by the National Natural Science Foundation of China and several Jiangsu provincial research programs, and all procedures were approved by the Affiliated Brain Hospital of Nanjing Medical University with written informed consent obtained from all participants. The authors declared no competing interests, and the article is published open access, making the full methods and results available for scrutiny by other research groups.

Caution is still warranted before the findings translate into routine practice. Resting-state fMRI measures indirect signals of neural activity, and Granger causality applied to slow hemodynamic data remains a subject of methodological debate, since the technique estimates influence from temporal precedence in signals that are delayed and blurred relative to the underlying neural firing. The AUC of 0.81, while respectable, is not diagnostic certainty, and the cohorts were drawn from clinical settings in China, raising questions about how the signature will generalize across populations, scanners, and medication states. Replication by independent teams, ideally with multimodal imaging that combines functional connectivity with measures of neurotransmitter function or electrophysiology, will be needed to establish whether the blunted cerebello-basal ganglia-thalamic flow is a cause of melancholic symptoms, a consequence, or a correlated marker.

Even with those caveats, the study represents a meaningful advance in the effort to bring biological precision to one of psychiatry’s most consequential distinctions. Melancholic depression affects a substantial share of the roughly 280 million people worldwide living with depression, and its resistance to treatment makes accurate identification a matter of urgent clinical value. A stable, directional, and replicable circuit signature, detectable with a standard resting-state MRI scan and validated across more than fifteen hundred brains, offers psychiatry something it has long sought: a way to see the subtype not just in a patient’s description of their suffering, but in the wiring of the brain itself. If future work confirms and extends these results, the quiet dialogue between the cerebellum, the basal ganglia, the thalamus, and the nucleus accumbens may become a focal point for diagnosing melancholic depression and, ultimately, for designing therapies that restore the flow of information this study found to be missing.

Subject of Research: Directed connectivity abnormalities in the cerebello-basal ganglia-thalamic circuit in melancholic major depressive disorder

Article Title: Blunted cerebello-basal ganglia-thalamic circuit connectivity in melancholic depression

Article References: Wang, X., Xia, Y., Wang, Y., Shen, N., Sheng, J., Chen, W., Bao, J., Yan, R., Yao, Z., & Lu, Q. (2026). Blunted cerebello-basal ganglia-thalamic circuit connectivity in melancholic depression. Translational Psychiatry. https://doi.org/10.1038/s41398-026-04502-8

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04502-8

Keywords: melancholic depression, major depressive disorder, resting-state fMRI, Granger causality, cerebellar vermis, nucleus accumbens, thalamus, basal ganglia, anhedonia, brain connectivity, biomarker, Translational Psychiatry

The performer was a right-handed, 30-year-old professional male pianist in excellent health, who began musical training at age four and had performed at major venues in New York, Nagoya, and Hong Kong. He played six works without interruption: four Contrapuncti from Bach’s Die Kunst der Fuge, the Adagio section of Beethoven’s Piano Sonata No. 31 in A-flat major, Op. 110, and an excerpt from Chopin’s Ballade No. 1 in G minor, Op. 23. The continuous-performance design was central to the study’s ecological aim. A trial-based design, in which short passages are repeatedly performed under explicit emotional instructions, would have interrupted interpretative continuity and forced the pianist to adopt externally imposed categorical labels such as Joy or Melancholy. Instead, phrasing, timing, dynamics, and motor organization unfolded naturally, and the expressive profiles were identified afterward by independent listeners.

From the continuous recording, the team extracted 99 two-second clean EEG segments, each containing 1,024 time points per channel, or 131,072 EEG data points per fragment. The segments were assigned to one of six previously validated performance-emotion categories based on listener evaluations: Joy, Peacefulness, Melancholy, Argumentative/Proactive, Tension, and Power. In the companion behavioral validation study, 20 professional musicians rated longer musical phrases in a forced-choice task, and one-sample t-tests confirmed that mean accuracy for every category exceeded the 16.67 percent chance level. A machine-learning analysis using Support Vector Machine, Random Forest, and Gradient Boosting algorithms further showed that the excerpts elicited sufficiently robust and discriminable oscillatory brain activity to permit reliable computational decoding of emotional performance states, with the Random Forest classifier providing the highest accuracy.

Cortical and subcortical source generators were reconstructed with standardized weighted Low-Resolution Electromagnetic Tomography, or swLORETA, an extension of sLORETA that incorporates singular-value-decomposition-based lead-field weighting to improve depth accuracy and localization stability under noisy conditions. The analysis yielded 1,056 dipoles, each associated with its gyrus and Brodmann area. Activation was quantified both as frequency of occurrence and as dipole magnitude across three macro-regions: anterior, posterior, and subcortical. A chi-square test on activation frequencies showed a significant association between region and emotional category, and repeated-measures ANOVAs revealed significant region- and emotion-dependent differences in dipole magnitude.

Across virtually every emotional category, the left basal ganglia, left thalamus, and left precentral gyrus (BA4) emerged as the most consistently recruited generators, indicating a stable left-lateralized fronto-striato-thalamic axis subserving fine motor control within this performance. The basal ganglia were active in 85 to 100 percent of segments in every category, and the left subcortical complex reached 100 percent occurrence in Argumentative/Proactive, Joy, and Power. Superimposed on this stable motor substrate, emotion-specific modulations emerged. Joy was associated with the highest subcortical activation magnitude, while Melancholy showed the lowest subcortical magnitude together with a selective recruitment of right-hemisphere generators, including right BA10, the right somatosensory cortex, and the right insula, consistent with valence-based hemispheric asymmetry accounts.

The magnitude analyses sharpened the contrast. Joy elicited the highest subcortical magnitude, differing significantly from Tension and, most markedly, from Melancholy, which showed the lowest subcortical magnitude overall. The sharpest gradient was observed between Joy, with left thalamic magnitude of 6.59 and left basal ganglia magnitude of 6.37, and Melancholy, with left thalamic magnitude of 2.31 and left basal ganglia magnitude of 2.10. Power was further distinguished by increased right cerebellar and right thalamic magnitude alongside a renewed left thalamic peak, not observed for any other category, suggesting heightened demands on motor error-monitoring during forceful and acoustically intense performance.

Pearson correlations further linked activation of the left basal ganglia, left thalamus, and left premotor cortex (BA6) to objective performance parameters, including gestures per second, notes per phrase, and acoustic intensity, suggesting that neurofunctional engagement scales with the motor complexity of the material performed. Left basal-ganglia and left thalamic activation magnitude correlated positively with gestures per second, indicating stronger subcortical recruitment during performances characterized by higher motor output. In contrast, left insular activation magnitude correlated negatively with the overall number of notes per musical phrase and, more strongly, with the number of left-hand notes per phrase, suggesting reduced insular recruitment during note-dense passages that may rely more on automatized subcortical control than on sustained interoceptive monitoring.

The authors caution that the emotional categories refer not to emotions necessarily experienced by the pianist, but to those perceived by listeners. These perceptual judgments arise from the interaction between the performer’s expressive interpretation and the structural characteristics of the musical piece. The naturalistic design is a major strength for ecological validity, but it prevents a clean separation of affective modulation from the motor-acoustic properties through which emotion is communicated. Moreover, because the 99 EEG segments were obtained from a single continuous performance and were nested within musical phrases, the observations cannot be regarded as fully independent, and the inferential statistics should be interpreted cautiously as exploratory within-performance analyses rather than as population-level evidence.

Despite these constraints, the findings provide a performer-side perspective complementary to models of music-evoked emotion largely derived from listeners, and suggest that, in this elite performer, expressive intent was instantiated in a specialized, left-dominant sensorimotor-limbic network modulated by affective valence. The study is complemented by animated audiovisual materials that dynamically trace the moment-to-moment evolution of LORETA source activity in synchrony with the unfolding musical passage, offering a vivid window into the neural choreography of expressive performance.

Subject of Research: Neuroscience of music performance

Article Title: Neural dynamics of emotionally expressive piano performance: a single-case study

Article References: Proverbio, A. M., & Carta, G. (2026). Neural dynamics of emotionally expressive piano performance: a single-case study. Frontiers in Cognition, 5, Article 1945714. https://doi.org/10.3389/fcogn.2026.1945714

Image Credits: AI Generated

DOI: 10.3389/fcogn.2026.1945714

Keywords: EEG, swLORETA, piano performance, music-evoked emotion, hemispheric lateralization, motor expertise, basal ganglia, thalamus, Neural, dynamics, emotionally, expressive

The research team, led by investigators affiliated with hospitals and medical colleges in Yancheng and Nantong, China, took a fundamentally different approach to the puzzle. Rather than asking where in the brain gray matter changes occur, they asked what functional network those changed regions belong to. The underlying idea, drawn from a rapidly growing movement in neuroscience, is that brain disorders are best understood not as problems of isolated spots but as disturbances of interconnected networks. When different anatomical locations produce similar clinical pictures, it is often because they are wired into the same functional circuit. The team used a technique called functional connectivity network mapping, or FCNM, to test whether the spatially scattered gray matter findings in IGE might converge on a shared network architecture.

To build their dataset, the researchers systematically searched PubMed, Embase, and Web of Science following PRISMA guidelines, ultimately identifying 18 whole-brain VBM studies of IGE published up to May 2026. These studies collectively reported 111 peak coordinates of gray matter alteration from 1,492 participants, including 694 patients and 798 healthy controls. The epilepsy subtypes represented ranged from juvenile myoclonic epilepsy—the most frequently studied—to childhood absence epilepsy, juvenile absence epilepsy, and epilepsy with generalized tonic-clonic seizures alone. Patient ages spanned from early childhood to middle adulthood, and disease durations ranged from a few months to two decades. Crucially, the team pooled coordinates reflecting both increased and decreased gray matter in their primary analysis, treating the direction of change as secondary to the question of network membership.

The methodological heart of the study lies in how those coordinates were transformed into a network map. Each of the 18 patient-control contrasts yielded its own set of gray matter coordinates, which were converted into 4-millimeter-radius spherical seeds. Using resting-state functional MRI data from 1,093 healthy adults in the Human Connectome Project S1200 release, the researchers calculated whole-brain functional connectivity maps for each seed by correlating the seed’s mean time series with that of every other brain voxel. Pearson correlations were converted to Fisher’s z values, individual maps were combined through one-sample t-tests, and the resulting group-level maps were thresholded using voxel-wise false discovery rate correction at p < 0.05. Only positive connectivity was considered, reflecting ongoing debate about the biological interpretation of negative connectivity measures. The binarized maps from all 18 contrasts were then overlaid, and only voxels showing positive connectivity with at least 60 percent of the contrast-specific seeds were retained in the final network—a criterion previously validated in FCNM studies.

The result was striking. Despite the anatomical scatter of the input coordinates, the analysis revealed a coherent, distributed normative connectivity pattern anchored in four principal regions: the bilateral middle temporal gyri, the bilateral thalami, the left superior frontal gyrus, and the right putamen. When the team measured how much of this network overlapped with eight canonical brain networks—seven cortical networks defined by the Yeo parcellation plus a subcortical network delineated from the Human Brainnetome Atlas—the subcortical network dominated, accounting for 42.77 percent of the overlap. The default mode network, a cortical system involved in self-referential thinking and internally directed cognition, came in a distant second at 11.06 percent. Overlap with the visual, somatomotor, dorsal attention, ventral attention, limbic, and frontoparietal networks each fell below 10 percent.

Replication is where many neuroimaging findings falter, so the team put their network to the test. They repeated the entire FCNM procedure using an independent, cross-scanner validation cohort: the Southwest University Adult Lifespan Dataset, comprising 329 healthy individuals scanned on a different 3 Tesla Siemens system. The validation analysis produced a broadly similar spatial pattern, with the subcortical network again showing the greatest overlap at 43.98 percent. The default mode network correspondence, however, was noticeably weaker in the validation dataset than in the discovery analysis—a discrepancy the authors attribute partly to the wider age range of the SALD sample and to differences in preprocessing pipelines, including the use of ICA-FIX denoising in the Human Connectome Project data but not in SALD.

Sensitivity analyses reinforced the robustness of the subcortical signal while exposing the fragility of the cortical component. When the researchers varied the seed radius from 4 millimeters to 1 and 7 millimeters, the resulting maps preserved their dominant subcortical and default mode overlap. When they separated gray matter increases from decreases, a potentially intriguing dissociation emerged: decreased gray matter foci showed their greatest overlap with the subcortical network at 65.84 percent, while increased gray matter foci aligned more with the default mode network at 37.23 percent. The authors caution that these direction-specific analyses rest on fewer contrasts and should be treated as hypothesis-generating rather than definitive. A leave-one-contrast-out analysis, in which each of the 18 contrasts was excluded in turn and the FCNM procedure repeated, found that 14 of the 18 resulting maps—77.7 percent—reproduced the major network pattern.

The convergence on the thalamus and putamen carries substantial biological weight. The thalamus has long been implicated in generalized epilepsies: structural MRI studies have documented thalamic volume and morphology abnormalities in childhood absence epilepsy, juvenile myoclonic epilepsy, and generalized tonic-clonic seizures, and functional imaging has captured thalamic activation during typical absence seizures coinciding with generalized spike-and-wave discharges. Neurochemical work has revealed altered GABA concentrations in the frontal lobe and thalamus of patients with juvenile myoclonic epilepsy. The putamen, meanwhile, has emerged as a subcortical hub in generalized epilepsy pathogenesis, with multimodal imaging revealing microstructural integrity deficits and diminished dopamine D2/D3 receptor binding that may weaken the basal ganglia’s inhibitory grip on pathological cortical discharges. Prior intracranial EEG research has further shown that interictal thalamocortical network configuration tracks susceptibility to consciousness-impairing seizures, and thalamic deep brain stimulation and vagus nerve stimulation are thought to act partly by restoring normative thalamocortical rhythms.

The default mode network component of the findings is more tentative. The middle temporal gyrus and superior frontal gyrus nodes identified in the study are known to participate in cognitive and emotional processing, and previous work has documented both structural and functional abnormalities in these regions in juvenile myoclonic epilepsy. Broader epilepsy literature has consistently reported altered functional connectivity within the default mode network across multiple syndromes, particularly at the posterior cingulate cortex and precuneus, and dynamic analyses suggest these subtle network anomalies may be more sensitively captured by temporal variability measures than by static connectivity. Yet because the DMN overlap was not comparably reproduced in the validation dataset, the authors interpret it as a secondary, exploratory observation rather than a definitive network-level finding.

The researchers are careful to frame their conclusions within important limits. Because the functional connectivity was derived entirely from healthy adults, the identified network represents the normative connectivity profile of reported gray matter alteration sites, not direct evidence of abnormal connectivity in patients. No coordinate-based permutation or spatially constrained null-model analysis was performed, so the study cannot establish that the observed overlap exceeds chance expectation or that it is disease-specific—particularly given the thalamus’s inherently broad connectivity. The developmental mismatch between the adult normative connectome and pediatric patient samples, the heterogeneity of scanners and analytic methods across the included studies, and the absence of negative findings from the original literature all add uncertainty. Still, the authors argue that their findings provide preliminary, descriptive evidence that the scattered gray matter alterations of IGE are embedded within a reproducible subcortical normative connectivity pattern, reframing IGE as a distributed cortico-subcortical network disorder and offering a framework that may guide future network-based biomarkers and candidate targets for neuromodulation.

Subject of Research: Normative functional network localization of gray matter alterations in idiopathic generalized epilepsy

Article Title: Normative functional network localization of gray matter alterations in idiopathic generalized epilepsy

Article References: Wang, X., Zhang, Z.-P., Zheng, B.-C., Liu, L., Wang, G.-D., Yang, H.-C., & Ma, L.-L. (2026). Normative functional network localization of gray matter alterations in idiopathic generalized epilepsy. Frontiers in Neurology, 17, Article 1957963. https://doi.org/10.3389/fneur.2026.1957963

Image Credits: AI Generated

DOI: 10.3389/fneur.2026.1957963

Keywords: idiopathic generalized epilepsy, gray matter, voxel-based morphometry, functional connectivity network mapping, thalamus, putamen, default mode network, subcortical network, resting-state fMRI, Human Connectome Project, juvenile myoclonic epilepsy, brain networks

The pulvinar is no ordinary relay. While early textbook accounts cast the thalamus as a simple switching station funneling sensory signals to the cortex, the pulvinar sits at the top of the hierarchy as a higher-order hub, coordinating communication between distant cortical networks. It is densely interconnected with visual, attentional, and association cortices, and it has been implicated in attentional filtering, visual salience assignment, and the integration of information across brain-wide networks. Because cortico-cortical pathways in schizophrenia have repeatedly shown disruption in imaging studies, and because the pulvinar orchestrates precisely such long-range coordination, the research team led by Yuanjun Xie and Qiang Hu reasoned that individualized deviations in pulvinar-cortical connectivity might carry a signature of clinical heterogeneity that conventional group-average analyses wash out.

To test that idea, the team assembled resting-state functional MRI data from 746 healthy controls and 387 patients with schizophrenia drawn from multiple scanning sites—a scale that matters, because site-specific differences in scanners and protocols can masquerade as biological signals if not carefully handled. Rather than comparing patients to controls as groups, the researchers built a normative model from the healthy reference data. Normative modeling is a technique borrowed in spirit from growth charts in pediatrics: instead of asking whether a group differs on average, it estimates, for each individual, how far that person’s brain features deviate from the expected range given the healthy population. Each patient thus received an individualized deviation profile describing where and how strongly their pulvinar-cortical functional connections strayed from the norm.

The next challenge was dimensional reduction guided by clinical relevance. Raw connectivity deviation maps contain thousands of features, far too many to cluster meaningfully without the solution being dominated by noise. The team therefore applied a symptom-guided feature selection strategy, retaining the connections whose deviations tracked symptom measures, and then ran unsupervised clustering within this clinically enriched, low-dimensional feature space. Unsupervised clustering is deliberately blind to diagnosis labels; it simply asks whether patients fall into natural subgroups based on their brain deviation patterns. The answer was yes: two partially separable biotypes emerged, and critically, they were not arbitrary mathematical artifacts but carried clinical meaning.

That meaning was anchored most strongly in negative symptom severity. The two biotypes differed significantly on this clinical dimension, and the difference survived statistical adjustment for scanning site and other available covariates—a crucial robustness check in multisite psychiatry research, where demographic and technical confounds can easily manufacture spurious subgroups. In other words, the brain-based split corresponded to a real, measurable difference in how ill patients were in the negative-symptom domain, the domain that most strongly predicts long-term functional outcome and that has proven most resistant to existing antipsychotic medications.

Where in the brain did the symptom-relevant deviations live? The connections that drove the biotype separation showed a structured cortical distribution, concentrated predominantly in the somatomotor, visual, and ventral attention networks. This distribution is intriguing on several counts. The somatomotor network’s involvement resonates with the well-documented motor abnormalities in psychosis, including soft neurological signs and psychomotor slowing that often precede overt illness. The visual network’s prominence fits with the pulvinar’s role as the principal higher-order nucleus of the visual system, and the ventral attention network’s contribution aligns with the salience-processing disturbances long proposed to underlie psychotic experience. Together, the pattern suggests that schizophrenia’s heterogeneity is written, at least in part, into how the pulvinar dialogues with specific cortical systems rather than being a diffuse, nonspecific connectivity decline.

To add molecular context to the circuit-level findings, the team performed imaging-transcriptomic analyses, which link spatial patterns of brain deviation to the spatial expression maps of genes across the cortex. These analyses were explicitly exploratory, but they yielded coherent profiles. Biotype 1 was associated with enrichment of biological processes involving translation, protein targeting, and synaptic organization—pathways pointing toward the machinery that builds and maintains synapses. Biotype 2 showed a distinct profile involving neurodevelopment, synaptic remodeling, and metal-ion homeostasis, hinting at altered developmental and plasticity programs and at the regulation of ions such as zinc and copper that shape synaptic function. The two molecular fingerprints, like the two connectivity patterns, were related but distinguishable, consistent with the notion of partially separable biologies under one diagnostic umbrella.

The researchers also stress-tested their solution. Site-exclusion analyses, in which the clustering was repeated while leaving out individual scanning sites, indicated that the biotype solution was partially stable, although the degree of clinical separation varied from site to site. That variation is an honest caveat: it signals that while the framework captures something real, its sensitivity is not yet uniform across acquisition environments, and multisite harmonization remains a live challenge for connectomic psychiatry.

Perhaps the most clinically provocative—and most cautiously framed—result came from a projection into an independent cohort of patients receiving repetitive transcranial magnetic stimulation, a noninvasive brain stimulation treatment sometimes used for resistant symptoms. When the biotype assignments derived from the pulvinar-cortical deviation framework were applied to this treatment cohort, the researchers observed nominal, uncorrected differences in negative symptom improvement at two weeks between biotypes. However, those differences were not sustained at the four-week follow-up, and the authors are explicit that the finding should be considered hypothesis-generating rather than evidence that the biotypes predict treatment response. Still, the exercise sketches a tantalizing path forward: if brain-defined subgroups could eventually be shown to respond differently to specific interventions, biotyping could move from descriptive science toward personalized treatment selection.

The study’s authors are careful about what their work does and does not establish. The findings support a symptom-guided, pulvinar-centered framework for characterizing schizophrenia’s heterogeneity, but independent replication using prespecified models is required before the biotypes can be considered clinically or biologically valid. That caution is warranted in a field where data-driven subtyping has a history of solutions that fail to travel across datasets. Yet the combination of a large sample, an individualized normative approach, clinical anchoring, covariate-adjusted robustness, molecular context, and a treatment-cohort projection represents an unusually complete methodological pipeline. If the two pulvinar-cortical biotypes hold up under independent replication, clinicians may one day supplement a symptom-based diagnosis with a circuit-based one—distinguishing, at the level of thalamocortical wiring, the different illnesses that today share a single name.

Subject of Research: Pulvinar-cortical functional connectivity deviations defining symptom-relevant schizophrenia biotypes

Article Title: Pulvinar-cortical connectomic deviations identify symptom-relevant biotypes in schizophrenia

Article References: Xie, Y., Liu, W., Guan, M., Yang, R., Wu, D., Ma, H., Wang, Z., & Hu, Q. (2026). Pulvinar-cortical connectomic deviations identify symptom-relevant biotypes in schizophrenia. Translational Psychiatry. https://doi.org/10.1038/s41398-026-04495-4

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04495-4

Keywords: schizophrenia, pulvinar, thalamus, connectomics, normative modeling, resting-state fMRI, negative symptoms, biotypes, imaging transcriptomics, transcranial magnetic stimulation, brain networks, psychiatry

The research, led by Guillaume Carey of Maastricht University’s Mental Health and Neurosciences Research Institute together with colleagues in the Netherlands and France, drew on participants from the TRACK-PD cohort, a longitudinal study registered in the Dutch Trial Register. The team enrolled 105 non-demented people with Parkinson’s disease, of whom 31 experienced clinically significant anxiety and 74 did not, alongside 37 healthy controls. All participants underwent structural brain scanning on a 7 Tesla MRI scanner, a strength of the study because ultra-high-field imaging provides far greater anatomical detail than the 3 Tesla scanners used in most clinical settings.

The structures of interest were small but critically important: the amygdala, the hippocampus, the nucleus accumbens, the caudate nucleus, the putamen, and the thalamus. These nuclei sit at the heart of the brain’s circuitry for emotion, reward, and threat processing, and they are also heavily affected by the dopaminergic neurodegeneration that defines Parkinson’s disease. Because several of them are only a few cubic centimeters in size, reliably measuring their boundaries requires both high-resolution imaging and sophisticated computational segmentation, which is precisely where the new study pushed the field forward.

To extract quantitative measures from the scans, the researchers used FastSurfer, a deep-learning-based segmentation pipeline, to delineate each subcortical structure automatically. They then went beyond simple volume measurements by applying a shape analysis technique known as the Spherical Harmonics Point Distribution Model, or SPHARM-PDM. This method represents each three-dimensional structure as a smooth mathematical surface and identifies localized regions of inward or outward deformation. The approach matters because two structures can have identical overall volumes while differing dramatically in shape, and shape deformations can reveal where neurodegeneration or remodeling is concentrated within a nucleus.

The results were striking. Anxiety severity in the Parkinson’s patients was significantly associated with a bilateral reduction in caudate volume, meaning that the more anxious a patient was, the smaller the caudate nuclei appeared on both sides of the brain. The caudate, part of the striatum, is a major hub of the brain’s reward and motivation circuitry and is densely connected to prefrontal regions that regulate worry and fear. Its involvement fits with a growing understanding that anxiety in Parkinson’s is not simply a psychological reaction to a difficult diagnosis but may reflect degeneration in specific neural circuits.

Shape analysis added a second layer of evidence. Compared with non-anxious Parkinson’s patients, those with anxiety showed distinct shape deformations in the bilateral caudate, the bilateral thalamus, the left nucleus accumbens, and the left amygdala. When the anxious patients were compared with healthy controls, significant shape differences emerged in the left amygdala and left thalamus. The thalamus acts as a relay station funneling sensory and emotional information to the cortex, while the amygdala is the brain’s central threat-detection structure, and the nucleus accumbens anchors the reward system. Localized deformation in these nuclei suggests that anxiety in early Parkinson’s is accompanied by structural remodeling across a distributed emotional network rather than a single focal lesion.

One of the most important aspects of the study is its focus on early-stage disease. Most imaging research on psychiatric symptoms in Parkinson’s has examined patients in mid or late stages, when medication effects, motor complications, and widespread neurodegeneration make it difficult to isolate the biology of any single symptom. By restricting the analysis to non-demented patients in the early phase, the researchers could ask a cleaner question: does anxiety have its own structural signature before the disease has extensively reshaped the brain? The answer, based on these findings, appears to be yes.

The authors propose that these morphometric changes could serve as potential imaging markers for the occurrence and progression of anxiety in early Parkinson’s disease. Such markers would be valuable for several reasons. Anxiety in Parkinson’s is frequently under-recognized and under-treated, partly because patients and clinicians may attribute distress to the burden of the diagnosis itself. An objective neuroimaging correlate could help distinguish anxiety rooted in circuit degeneration from situational distress, guide screening for patients at highest risk, and provide a measurable outcome for clinical trials of new interventions targeting neuropsychiatric symptoms.

The study also carries caveats typical of cross-sectional designs. Because the data were captured at a single time point, the findings show association rather than causation; they cannot determine whether caudate atrophy precedes anxiety, follows it, or reflects a shared underlying degenerative process. The anxious group was also relatively small, with 31 patients, and longitudinal follow-up will be needed to establish whether the observed shape and volume changes predict the future course of anxiety symptoms. The authors and the TRACK-PD infrastructure are well positioned to address these questions as the cohort continues to be followed over time.

Nevertheless, the study represents a technical and conceptual step forward. It demonstrates that 7 Tesla MRI, combined with automated segmentation and harmonic shape modeling, can resolve subtle structural differences in deep brain nuclei that conventional imaging would likely miss. It reframes anxiety in Parkinson’s disease as a circuit-level phenomenon with detectable anatomical correlates, and it offers the research community a concrete set of candidate biomarkers centered on the striatum, thalamus, and amygdala. If future longitudinal work confirms these signatures, ultra-high-field morphometry could become a practical tool for identifying which patients with early Parkinson’s are most likely to develop anxiety, and for tracking whether new treatments protect both the motor and the emotional brain.

Subject of Research: Subcortical brain structure changes associated with anxiety in early Parkinson's disease detected by 7T MRI

Article Title: Alterations of subcortical structures are associated with anxiety in early Parkinson’s disease patients: a cross-sectional 7T MRI study

Article References: Carey, G., van Lier, M., Michielse, S., Wolters, A. F., Dujardin, K., Kuijf, M. L., & Leentjens, A. F. G. (2026). Alterations of subcortical structures are associated with anxiety in early Parkinson’s disease patients: a cross-sectional 7T MRI study. npj Parkinson's Disease. https://doi.org/10.1038/s41531-026-01532-3

Image Credits: AI Generated

DOI: 10.1038/s41531-026-01532-3

Keywords: Parkinson's disease, anxiety, 7T MRI, caudate nucleus, amygdala, thalamus, nucleus accumbens, subcortical structures, SPHARM-PDM, neuroimaging biomarkers, non-motor symptoms, TRACK-PD cohort

Adolescence is widely recognized as a sensitive window for both brain development and mental health. Many psychiatric conditions, including anxiety disorders, make their first appearance during these years, yet the precise relationship between the developing brain’s changing architecture and the emergence of symptoms has remained incompletely understood. The stakes are considerable: anxiety disorders, including generalized anxiety disorder and social anxiety disorder, affect more than 30 percent of teenagers in the United States, making them among the most common mental health conditions of youth. Understanding which neural systems are involved, and how early their signatures become detectable, could reshape when and how clinicians intervene.

The study was led by Caterina Stamoulis, PhD, Principal Investigator in the Computational Neuroscience Laboratory at Boston Children’s Hospital. Her team took advantage of the Adolescent Brain Cognitive Development Study, or ABCD, the largest long-term study of brain development and child health ever conducted in the United States. By examining associations between the structural characteristics of brain regions, the organization of the circuits they form, and measures of anxiety across a sample of nearly 3,500 youth, the researchers sought to move beyond broad correlations between whole-brain measures and behavior and instead identify specific networks implicated in the disorder.

What they found was a circuit composed of three structures: the cerebellum, the amygdala, and the thalamus. Each of these plays a distinctive role in brain function. The amygdala, buried deep in the temporal lobes, is central to processing threat and emotional salience. The thalamus acts as a major relay station, gating the flow of sensory and other information to the cortex. The cerebellum, long associated with motor coordination, is now understood to participate in a wide range of cognitive processes and to exert regulatory roles over brain function more broadly. In youth with anxiety, the organization of this three-node circuit was altered, and the strength of its connections was reduced.

Those alterations were not merely correlates of a diagnostic label. The researchers report that weaker and less well-organized connections within the circuit were associated with higher levels of anxiety and with a greater likelihood of related disorders. In other words, the circuit’s properties varied in a graded fashion with symptom severity, a pattern consistent with the idea that the circuit is functionally involved in the mechanisms of anxiety rather than simply marking its presence. At the same time, the study identified a protective counterpart: the efficiency and resilience, or robustness, of other brain networks were associated with lower risk of social and generalized anxiety disorders. The developing brain, in this view, is not a single system tipping toward or away from illness but a collection of networks whose competing properties shape mental health outcomes.

The findings did not stop at circuit organization. The team also identified structural alterations in the brains of youth with anxiety, and crucially, they found that these structural and circuit alterations were associated with reduced performance in a specific cognitive domain: the ability to perceive, process, and integrate information about spatial locations and the relationships between objects and shapes. This capacity, known as visuospatial processing, is far from an abstract laboratory construct. It underpins everyday tasks ranging from navigating spaces and driving a car to assembling furniture and tying shoes. The implication is that anxiety in adolescence may be accompanied by measurable deficits in cognitive skills that young people rely on daily, a connection that has rarely been drawn so explicitly in previous work.

Perhaps the most consequential finding concerns timing. The anxiety-related brain alterations were already measurable at ages 11 to 12, a point at which many of the study participants had not yet developed clinically significant anxiety symptoms. This early detectability reframes the clinical picture. If the neural signatures of vulnerability are present before the full syndrome emerges, then the window for preventive intervention opens years earlier than current practice typically assumes. Waiting for symptoms to become impairing may mean intervening after the brain’s developmental trajectory has already been shaped, whereas earlier action could minimize long-term cognitive deficits and mental health problems.

Stamoulis sees in these results an argument for precision medicine applied to psychiatry. The identification of specific circuits implicated in anxiety, she suggests, provides concrete targets for interventions designed to improve both short-term and longer-term mental health outcomes in youth. Rather than treating adolescent anxiety as a homogeneous condition addressed with one-size-fits-all approaches, clinicians could in principle use neuroimaging markers to identify which young people show alterations in this cerebellar-amygdala-thalamic circuit and tailor treatments accordingly. Such precision psychiatry, she notes, is likely to play an important role in future mental health care, though the study itself establishes associations rather than demonstrating that altering the circuit directly changes anxiety outcomes.

The methodological strength of the work lies in its scale and its analytical approach. Studies of adolescent brain development have often been limited by small samples, which make it difficult to distinguish genuine neural signatures from statistical noise. By drawing on the ABCD cohort, the Boston Children’s team could examine circuit properties across a large and diverse population of youth, increasing confidence that the associations they observed reflect robust features of the developing brain rather than artifacts of a particular group. The combination of structural measures, network organization metrics, cognitive testing, and clinical assessments of anxiety allowed the researchers to connect levels of analysis that are usually studied in isolation.

The broader significance of the study extends beyond anxiety itself. By showing that a defined circuit involving the cerebellum, amygdala, and thalamus carries both emotional and cognitive consequences, the work reinforces a growing recognition that mental health and cognition are intertwined at the level of brain networks. It also highlights the value of large longitudinal resources like ABCD, which allow scientists to track how brain organization and behavior co-evolve across adolescence. For the millions of teenagers affected by anxiety, and for the clinicians who treat them, the study offers a concrete starting point: a map of where to look, a timeline for when to look, and a rationale for acting before symptoms take hold. As precision interventions are developed and tested, the circuit identified by Stamoulis and her colleagues may well become one of the first neural targets in a new era of youth mental health care.

Subject of Research: Neural circuit alterations associated with adolescent anxiety identified through large-scale neuroimaging of the developing brain

Article Title: Researchers identify specific brain circuits associated with anxiety in adolescents

Article References: Researchers identify specific brain circuits associated with anxiety in adolescents. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: adolescent anxiety, brain circuits, cerebellum, amygdala, thalamus, ABCD study, neuroimaging, precision psychiatry, visuospatial processing, brain development, Boston Children's Hospital, Imaging Neuroscience